Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 2/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | GLS | O94925 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.47 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8950475 | 1.00 | CASP3 (0.60) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL4468251 | 1.00 | CASP3 (0.60) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL21901972 | 0.92 | CASP3 (0.53) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL2319856 | 0.90 | CASP3 (0.51) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL9761279 | 0.90 | CASP3 (0.51) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL25302148 | 0.90 | CASP3 (0.51) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL9761288 | 0.90 | CASP3 (0.51) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL644937 | 0.90 | CASP3 (0.51) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL23077378 | 0.90 | CASP3 (0.51) | CASP3CA12CA9GLSALDH1A1 | |
| SCHEMBL12439955 | 0.90 | CASP3 (0.51) | CASP3CA12CA9GLSALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10563009-B2 | Process to produce a polyolefin reactive telechelic pre-polymer | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-02-18 | — | — | US | disclosed |
| EP-3087104-B1 | METHOD FOR CONTROLLED METATHESIS DEPOLYMERIZATION OF NATURAL RUBBER FROM NATURAL RUBBER LATEX | MICHELIN & CIE (FR) | 2019-11-13 | — | — | EP | disclosed |
| US-20180162998-A1 | A POLYOLEFIN REACTIVE TELECHELIC PRE-POLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-14 | — | — | US | disclosed |
| US-20180134840-A1 | PROCESS TO PRODUCE A POLYOLEFIN REACTIVE TELECHELIC PRE-POLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-05-17 | — | — | US | disclosed |
| EP-3303443-A1 | A PROCESS TO PRODUCE A POLYOLEFIN REACTIVE TELECHELIC PRE-POLYMER | Dow Global Technologies LLC (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-3303442-A1 | A POLYOLEFIN REACTIVE TELECHELIC PRE-POLYMER | Dow Global Technologies LLC (US) | 2018-04-11 | — | — | EP | disclosed |
| WO-2016191688-A1 | A PROCESS TO PRODUCE A POLYOLEFIN REACTIVE TELECHELIC PRE-POLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-01 | — | — | WO | disclosed |
| WO-2016191692-A1 | A POLYOLEFIN REACTIVE TELECHELIC PRE-POLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-01 | — | — | WO | disclosed |
| EP-3087103-A1 | METHOD FOR METATHESIS DEPOLYMERIZATION OF NATURAL RUBBER IN A SOLUTION | Compagnie Générale des Etablissements Michelin (FR) | 2016-11-02 | — | — | EP | disclosed |
| WO-2015097194-A1 | METHOD FOR METATHESIS DEPOLYMERIZATION OF NATURAL RUBBER IN A SOLUTION | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2015-07-02 | — | — | WO | disclosed |
| EP-1846365-A1 | DIAMINE CALCIUM CHANNEL BLOCKERS | Neuromed Pharmaceuticals, Ltd. (CA) | 2007-10-24 | — | — | EP | disclosed |
| WO-2006084369-A9 | DIAMINE CALCIUM CHANNEL BLOCKERS | NEUROMED PHARMACEUTICALS LTD (CA) | 2007-01-11 | — | — | WO | disclosed |
| US-20060235050-A1 | Diamine calcium channel blockers | NUEROMED TECHNOLOGIES, INC. (CA) | 2006-10-19 | — | — | US | disclosed |
| WO-2006084369-A1 | DIAMINE CALCIUM CHANNEL BLOCKERS | NEUROMED PHARMACEUTICALS LTD. (CA) | 2006-08-17 | — | — | WO | disclosed |
| US-5556968-A | Polyazamacrocycle chelating agents with amide linkages | NYCOMED SALUTAR, INC. (US) | 1996-09-17 | — | — | US | disclosed |
| US-5461079-A | Applying 2-butene-1,4-diamine to plants | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1995-10-24 | — | — | US | disclosed |
| EP-0588825-A1 | ANTIFUNGAL COMPOUNDS | BTG INTERNATIONAL LIMITED (GB) | 1994-03-30 | — | — | EP | disclosed |
| EP-0556240-A1 | CHELATING AGENTS. | COCKBAIN JULIAN R M (GB) | 1993-08-25 | — | — | EP | disclosed |
| WO-1992021235-A1 | ANTIFUNGAL COMPOUNDS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1992-12-10 | — | — | WO | disclosed |
| WO-1992008707-A1 | CHELATING AGENTS | COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) | 1992-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235050-A1 | Diamine calcium channel blockers | CACNA1G, CACNA1H, CACNA1I | CASP3 2170/4885CA12 2717/4885CA9 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.